Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Piezo1-mediated stellate cell activation causes pressure-induced pancreatic fibrosis in mice
Sandip M. Swain, Joelle M-J Romac, Steven R. Vigna, Rodger A. Liddle
Sandip M. Swain, Joelle M-J Romac, Steven R. Vigna, Rodger A. Liddle
View: Text | PDF
Research Article Gastroenterology

Piezo1-mediated stellate cell activation causes pressure-induced pancreatic fibrosis in mice

  • Text
  • PDF
Abstract

Pancreatic fibrosis is a complication of chronic pancreatitis and is a prominent feature of pancreatic cancer. Pancreatic fibrosis is commonly observed in patients with prolonged pancreatic duct obstruction, which elevates intrapancreatic pressure. We show here that increased pancreatic duct pressure causes fibrosis and describes the mechanism by which pressure increases deposition of extracellular matrix proteins and fibrosis. We found that pancreatic stellate cells (PSCs), the source of the extracellular matrix proteins in fibrosis, express the mechanically activated ion channel Piezo1. By increasing intracellular calcium, mechanical stress or the Piezo1 agonist Yoda1-activated PSCs manifest by loss of perinuclear fat droplets and increased TGF-β1, fibronectin, and type I collagen expression. These effects were blocked by the Piezo1 inhibitor GsMTx4 and absent in PSCs from mice with conditional genetic deletion of Piezo1 in stellate cells, as was pancreatic duct ligation–induced fibrosis. Although TRPV4 has been proposed to have direct mechanosensing properties, we discovered that PSCs from Trpv4-KO mice were protected against Yoda1-triggered activation. Moreover, mice devoid of TRPV4 were protected from pancreatic duct ligation–induced fibrosis. Thus, high pressure within the pancreas stimulates Piezo1 channel opening, and subsequent activation of TRPV4 leads to stellate cell activation and pressure-induced chronic pancreatitis and fibrosis.

Authors

Sandip M. Swain, Joelle M-J Romac, Steven R. Vigna, Rodger A. Liddle

×

Figure 5

Fluid shear stress–induced stellate cell activation and fibrosis in vitro.

Options: View larger image (or click on image) Download as PowerPoint
Fluid shear stress–induced stellate cell activation and fibrosis in vitr...
(A) Fluid shear stress (12 dyne/cm2 for 10 minutes) induced loss of fat droplets (green) stained with Bodipy 493/503 in human PSCs with and without GsMTx4 (5 μM). Images were taken 24 hours after shear stress. (B) Quantification of reduction in fat droplets 24 hours after shear stress (from 3 experiments and > 50 cells per experiment). (C and E) Representative images of fibronectin and collagen type I immunostaining in human PSCs 3 days after last application of shear stress. Shear stress (25 dyne/cm2 for 10 minutes) was applied twice at an interval of 24 hours. (D and F) Quantification of the fibronectin and collagen type I intensity was calculated from data shown in C and E. Data represent the mean ± SEM. Statistical analyses were calculated using 1-way ANOVA. **P ≤ 0.01, ***P ≤ 0.001; ****P ≤ 0.0001. Scale bar: 10 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts